RecruitingPhase 1NCT07311993
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Sponsor: Cellectar Biosciences, Inc.
Glen Burnie, MD · +3 more sites
Breast Cancer clinical trials in Glen Burnie, MD
8 recruiting breast cancer studies with a site in Glen Burnie, MD.
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
Glen Burnie, MD · +13 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Aberdeen, MD · Annapolis, MD · Baltimore, MD · +1223 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Annapolis, MD · Baltimore, MD · +825 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Baltimore, MD · +378 more sites
RecruitingPhase 1NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Sponsor: Orano Med Theranostics, SAS
Glen Burnie, MD · +6 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Baltimore, MD · +809 more sites
Not yet recruitingPhase not listedNCT07374796
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
Sponsor: University of Maryland, Baltimore
Glen Burnie, MD
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.